Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

Share Price is delayed by 15 minutes
Get Live Data
820.00    -11.00 (-1.32%)
Bid:
816.00
Ask:
822.00
Spread: 6.00 (0.735%)
Market Cap: £774.61m
POLR Live PriceLast checked at - London Stock Exchange

Intraday Polar Capital Share Chart

AuM Update

9 Jan 2020 07:00

RNS Number : 2064Z
Polar Capital Holdings PLC
09 January 2020
 

9 January 2020 Polar Capital Holdings plc

AuM Update

 

 

Polar Capital Holdings plc ("Polar Capital" or the "Group"), the specialist active asset management group, today provides its regular quarterly update of its unaudited statement of its Assets under Management ("AUM") and performance fees earned for the calendar year to 31 December 2019.

 

Group AUM (unaudited)

 

Polar Capital reports that as at 31 December 2019 its AuM were £14.2bn compared to £13.8bn at the end of March 2019, an increase of 3% over the period. During the period, AuM increased by £0.4bn which comprised net outflows of £1.1bn offset by an increase of £1.5bn related to market movement and fund performance.

 

AuM movement in nine months to 31 December 2019

Long-only

funds

Alternative funds

Total

AuM at

1 April 2019

£12,529m

£1,306m

£13,835m

Net subscriptions

£(1,132)m

£61m

£(1,071)m

Market movement

and performance

£1,397m

£60m

£1,457m

Total AuM at

31 December 2019

£12,794m

£1,427m

£14,221m

 

Net performance fees (unaudited)

 

The table below sets out the position relating to net performance fee profits (after the deduction of staff interests) earned in the first nine months of the Group's financial year.

 

Performance fee profit

net of staff allocations

Nine months to

31 Dec 18

Year to

31 Mar 19

(year-end)

Nine months to

31 Dec 19*

Net performance fee profit

£23.6m

£24.0m

£8.8m*

 

\* The figures to December 2019 are reduced by what is expected to be circa £1.4m of net deferment that IFRS requires to be deducted from this year's receipts.

 

 

Gavin Rochussen, Chief Executive, commented:

 

"Although AuM in the nine months has increased by £400m from £13.8bn to £14.2bn, it has been another challenging quarter. Net outflows of £623m were offset by an increase in AuM of £542m from market and performance movements resulting in a decline in AuM in the quarter of £81m.

 

"The election result and reduced Brexit uncertainty increased demand for our UK Value Fund which had net inflows of £100m in December. On the other hand, clients continued to reduce their exposure to North American equities. This led to net outflows from our North American Fund of £611m in the quarter, which includes the reallocation of a client mandate away from North American equities to alternative asset classes.

 

"The Japan Value Fund continued to perform well and had net inflows in December of £48m marking an end to multi-year monthly outflows from our Japan funds.

 

"In the nine month period to 31 December we were not immune to the challenging conditions experienced by the industry as a whole; total net outflows amounted to £1.1bn which was dominated by net outflows of £453m from the Japan Fund prior to the merger with the Japan Value Fund, net outflows from our North American strategy of £795m and an aggregate £500m redemption by a long-standing client in our Technology and Healthcare Funds.

 

"It is pleasing to report net inflows over the nine months into the majority of our Funds including Global Technology, Japan Value, UK Value Opportunities, GEM Stars, Asia and China Stars, Global Insurance, European ex-UK Income, Global Convertible Bonds, Global (Convertibles) Absolute Return, UK Absolute Equity and China Mercury.

 

"Fund performance across the range of our funds was strong in the last quarter of the calendar year resulting in crystallised net performance fee profits of £8.8m for the period to 31 December.

 

"Over three years annualised, 67% of our Funds and 81% of AuM have outperformed their respective benchmarks.

 

"We have a diverse and complementary range of fund strategies with proven track records. We remain confident that, over the long term, our active fundamental strategies will continue to deliver above average returns for our clients and compelling total returns for our shareholders."

 

 

 

For further information please contact:

 

Polar Capital

Gavin Rochussen (Chief Executive)

John Mansell (Executive Director)

Samir Ayub (Finance Director)

 

+44 (0)20 7227 2700

Numis Securities Limited - Nomad and Joint Broker

Charles Farquhar

Stephen Westgate

Kevin Cruickshank (QE)

+44 (0)20 7260 1000

 

 

Peel Hunt LLP - Joint Broker

Guy Wiehahn

Andrew Buchanan

 

+44 (0)20 7418 8893

 

Camarco

Ed Gascoigne-Pees

Monique Perks

 

+44 (0)20 3757 4995

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTEAKFPELSEEFA
Date   Source Headline
13th Apr 20237:00 amRNSAuM Update
31st Mar 202312:23 pmRNSDirector/PDMR Shareholding
10th Mar 20233:17 pmRNSDirector/PDMR Shareholding
24th Feb 20235:18 pmRNSForm 8.3 - REDX Pharma PLC
16th Feb 20235:06 pmRNSDirector/PDMR Shareholding
7th Feb 202311:09 amRNSHolding(s) in Company
1st Feb 20237:00 amRNSBlock listing Interim Review
12th Jan 20237:00 amRNSAuM Update
30th Dec 20227:00 amRNSDirectorate Change
21st Nov 20227:00 amRNSUnaudited interim results
15th Nov 20227:00 amRNSInvestor Presentation covering Interim Results
24th Oct 20227:00 amRNSNotice of Results
19th Oct 20222:52 pmRNSDirector/PDMR Shareholding
13th Oct 20227:00 amRNSAuM Update
29th Sep 202210:33 amRNSHolding(s) in Company
7th Sep 20224:18 pmRNSResult of AGM
31st Aug 20222:03 pmRNSForm 8.3 - Diurnal Group PLC
26th Aug 20229:20 amRNSHolding(s) in Company
1st Aug 20227:00 amRNSBlock listing Interim Review
21st Jul 202212:14 pmRNSDirector/PDMR Shareholding - Replacement
20th Jul 202210:57 amRNSDirector/PDMR Shareholding
20th Jul 202210:26 amRNSDirector/PDMR Shareholding
14th Jul 20224:11 pmRNSHolding(s) in Company
14th Jul 20227:00 amRNSAuM Update
13th Jul 20223:25 pmRNSForm 8.3 - Serica Energy PLC
13th Jul 202210:23 amRNSDirector/PDMR Shareholding
6th Jul 20225:50 pmRNSDirector/PDMR Shareholding
29th Jun 20221:10 pmRNSHolding(s) in Company
27th Jun 20227:00 amRNSGroup Audited Results for year ended 31 March 2022
21st Jun 20227:00 amRNSInvestor Presentation covering Preliminary Results
15th Jun 202210:59 amRNSHolding(s) in Company
1st Jun 20227:00 amRNSTotal Voting Rights
26th May 202210:01 amRNSIssue of Equity
26th May 20227:00 amRNSNotice of Results
16th May 20224:26 pmRNSHolding(s) in Company
6th May 20224:55 pmRNSDirector/PDMR Shareholding
4th May 202212:15 pmRNSDirector/PDMR Shareholding
28th Apr 20222:38 pmRNSHolding(s) in Company
14th Apr 20227:00 amRNSAuM Update
12th Apr 20227:00 amRNSFund Terminations
11th Apr 20225:03 pmRNSHolding(s) in Company
30th Mar 20229:18 amRNSDirector/PDMR Shareholding
25th Feb 20221:03 pmRNSDirector/PDMR Shareholding
23rd Feb 20223:47 pmRNSForm 8.3 - Clipper Logistics plc
23rd Feb 20223:44 pmRNSForm 8.3 - Clipper Logistics plc
23rd Feb 20221:27 pmRNSDirector/PDMR Shareholding
22nd Feb 20221:12 pmRNSDirector/PDMR Shareholding
1st Feb 20222:53 pmRNSDirector/PDMR Shareholding
1st Feb 20227:00 amRNSBlock listing Interim Review
25th Jan 20225:09 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.